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Background
There are some strategies to improve adherence (AD)
and glycemic control (GC). Some barriers may be faced
by elderly diabetics. To identify factors that hinder the
treatment is essential.
Objectives
To evaluate the glycemic response after changing the
syringes (SY) for pens device (PD), and to identify possi-
ble “non-responders” (NR) to this treatment.
Materials and methods
This is a prospective, intervention, non-randomized, phase
IV study. We included patients over 60 yrs. old, both
sexes, with HbA1c>8.5% using oral hypoglycemic agents
and insulin (IN), then we replaced SY by PD. IN used
were NPH and Regular, all patients have received a blood
glucose monitor, lancet tapes, capillary blood glucose tests
(3 tests/day). HbA1c was measured at baseline, 3 and
6 months. Patients were seen monthly. We considered
“responders” (R) who showed improvement in HbA1c of
more than 0.4% after first 3 months (as used on clinical
practice).
Results
38 patients completed follow-up in the first quarter. 31
were considered R and 7 were considered NR. There
were no differences between the two groups for age,
gender, education, family income, race, religion, history
of smoking and alcohol consumption or presence of
chronic complications. R showed greater variation
(delta) of HbA1c in the first trimester compared to NR
(-2.17±1.33 vs. +0.35±0.99, p<0.001), and in six months
(R -2.40±1.36 vs. NR - 0.91±1.26, p=0.013). There was
no difference in the change in the second trimester, (R -
0.27±1.02 vs. NR 1.99±-1.27, p=0.238) and in HbA1c –
at baseline (R 10.28±1.5 vs. NR 9.78±1.88) and final (R
7.85±1.15 vs. NR 8.87±1.5), except in three months (R
8.10±1.09 vs. NR 10.14±1.88, p<0.001). There were no
differences in the use of regular, number of daily injec-
tions, total daily IN dose (UI/kg) or in relation to AD –
used IN doses counting (p=0.62). R had higher rates of
sulfonylurea use associated with metformin and IN
(p=0.001), and showed higher incidence of hypoglycemia
(p=0.009) until the sixth visit, with no differences in
severity and presence of nocturnal or asymptomatic
hypoglycemia.
Conclusion
We have found no differences in socio-cultural character-
istics or AD rates to justify different on response. R had
higher incidence of hypoglycemia and the use of IN asso-
ciated with sulfonylureas can increase this tendency. At
final, both groups had similar GC, and at this time, hypo-
glycemia was not different between them. Grants from
CNPq and Fundo de Incentivo a Pq. do HCPA (FIPE).
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